Advertisement CryoXtract wins NOA for frozen sample aliquotting technology patent application - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

CryoXtract wins NOA for frozen sample aliquotting technology patent application

The US Patent and Trademark Office (USPTO) has granted notice of allowance (NOA) to CryoXtract Instruments' patent application NO.12/823,628 covering Frozen Sample Aliquotting technology.

The patent entitled, ‘Systems, Methods and Devices for Frozen Sample Distribution’, covers the company’s core technology, which provides efficient access to the highly valuable frozen biosamples for important research and discovery.

In addition, the technology preserves the integrity of the original parent sample for future use, and streamlines sample processing and lab efficiency through automation.

The patent application is jointly owned by Harvard University and Northeastern University, which collaborated on the development of the technology.

CryoXtract CEO John McCarthy said, "The issuance of this Patent Allowance represents an important and foundational milestone for the Company, and validates the innovative accomplishments achieved to date by CryoXtract and its collaborators at Harvard and Northeastern."

The company, which is the exclusive licensee for the patent application, has also filed additional US and international patent applications directed to key enhancements and broadened applications for its technology.